搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Targeted Oncology
3 小时
The Targeted Pulse: A Review of Last Month’s FDA Prominent Actions and Key Data Updates ...
October 2024, saw significant FDA actions and clinical trial updates that shaped cancer treatment progress. Highlights include acalabrutinib’s approval for mantle cell lymphoma, T-DXd’s priority ...
Targeted Oncology
23 小时
Next Steps for Cilta-Cel and CARTITUDE-4 in Multiple Myeloma
Binod Dhakal, MD, MS, discusses some of the next steps for evaluating ciltacabtagene autoleucel in multiple myeloma and the CARTITUDE-4 trial.
Targeted Oncology
1 天
Adjuvant/Neoadjuvant Therapies Are Addressed in Lung Cancer
The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.
Targeted Oncology
1 天
Positive Trials Continue to Shape the SCLC Treatment Landscape
Additionally, positive findings from trials like ADRIATIC (NCT03703297) and IMforte (NCT05091567) are further shaping ...
Targeted Oncology
1 天
FDA Greenlights Obe-cel in Relapsed/Refractory B-ALL
The FDA approved obecabtagene autoleucel for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia.
Targeted Oncology
1 天
Sunvozertinib New Drug Application in EGFR-Mutant NSCLC Submitted to FDA
Sunvozertinib has shown promising results in patients with non–small cell lung cancer with an EGFR exon 20 insertion mutation ...
Targeted Oncology
1 天
Quadruplets Seen as Top Option in Transplant-Ineligible Multiple Myeloma Due to Efficacy
Samer A. Al'Hadidi, MD, MS, discusses the response and survival of 2 quadruplet therapy trials for patients with ...
Targeted Oncology
2 天
MARIPOSA-2: Second-Interim Survival Data
Panelist discusses how the second interim overall survival data from MARIPOSA-2, presented at the European Society for ...
Targeted Oncology
1 天
MB-108 Gains FDA Orphan Drug Status for Malignant Glioma Treatment
MB-108 shows activity and is well tolerated in recurrent glioblastoma, with preclinical data supporting its combination with ...
Targeted Oncology
2 天
Current Landscape of Checkpoint Inhibitors in SCLC
Chavez, MD, discusses the efficacy of immunotherapy for the potential treatment of extensive-stage small cell lung cancers.
Targeted Oncology
2 天
Checkpoint Inhibition and Targeted Therapy Move the Needle in Anaplastic Thyroid Cancer
Combining the checkpoint inhibitor atezolizumab with targeted therapy led to improvements in overall survival in patients ...
Targeted Oncology
1 天
Apalutamide Outperforms Enzalutamide in mCSPC Survival
In an interview with Targeted Oncology, Neal Shore, MD, FACS, discussed the background, findings, and implications of a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈